|

Immu-News
4Life® Transfer Factor™ Approved By the
Health Ministry of Russia for use in Hospitals and
Clinics!
First Ever
Dietary Supplement to be Approved for Use by Doctors and
Hospitals in Russia
SANDY, UT (October 1, 2004) - In an unprecedented
announcement in the history of network marketing, 4Life
announced today that 4Life Transfer Factor products as
immune modulators have been approved for use in
hospitals and clinics in the Russian Federation. The
results of ten separate clinical trials and two
experimental studies on 4Life Transfer Factor products
were combined in a Methodological Document that was
approved by the Ministry of Health, which now allows
doctors to recommend 4Life Transfer Factor Classic and
4Life Transfer Factor Plus® products to their patients.
First Dietary Supplement Approved for Use by Doctors and
Hospitals in Russia
Commenting on this remarkable achievement, David
Lisonbee, CEO of 4Life stated, “To my knowledge, this is
the first time in the history of this industry that a
network marketing company or any other dietary
supplement company has had one of its dietary
supplements approved for use in hospitals in Russia. The
Russian Ministry of Health is the equivalent of the Food
and Drug Administration in the United States. Doctors
and scientists from Russia have been working jointly
with scientists from 4Life for several years to arrive
at this accomplishment. This approval establishes a new
roll of dietary supplements in the Russian health care
system.
Remarkable Response from Russian Academy of Medical
Sciences
In another sector of research of 4Life Transfer Factor,
Dr. Kisielevsky of the Russian Academy of Medical
Sciences stated, “The 4Life sample [Transfer Factor
Advanced Formula] activated NK (natural killer) cell
activity more than the Interleukin-2 (IL2) drug we used
as the standard.” This discovery has attracted the
attention of The International Scientific and Technical
Center (ISTC) of Russia.
Scientists from Several Countries Join Forces for
Additional Clinical Studies of Transfer Factor
The ISTC of Russia is a member of a joint international
project with other health agencies of Japan, Europe and
the US. The objective of the international project is to
combine efforts in finding improved immunotherapies.
Following the discoveries from the NK cell testing, the
scientists of 4Life have been invited to join the
project. 4Life Transfer Factor as an immune modulator
will be further researched in this international forum.
The cost of the studies will be paid by the ISTC.
Worldwide Ramification
Speaking of this benchmark achievement, Dr. Calvin
McCausland, VP of Research of 4Life, and Dr. Emma
Oganova, 4Life/Eurasia President, jointly expressed that
because of the acceptance by such a reputable
organization and doctors from Russia and other major
countries, 4Life Transfer Factor will gain wider
acceptance in the professional and private sectors as a
superior immune system enhancing product. The worldwide
ramifications to this acceptance are just beginning.
4Life Research is the World’s foremost leader in the
development, production and distribution of natural
immune support products and was recently recognized by
Inc. magazine as the fifteenth fastest growing
privately-held company in America.
4Life Research Announces New Discovery - NanoFractions
September 21, 2007
(Salt Lake City, Utah) 4Life
Research™, the world leader in Transfer Factor science
and immune system support development, announced today
the discovery of immune activity in a weight range of
molecules significantly smaller than transfer factors.
Transfer
factors are molecules in a weight class between 3,500 -
12,000 daltons that help the immune system recognize,
respond to, and remember outside threats. Although
scientists have known that smaller molecules than
transfer factors existed within cow colostrum, their
significance in terms of immune activity has been
unknown until now.
In 2005,
4Life Chief Executive Officer David Lisonbee and the
Research and Development department began studying these
low weight molecules. After two years of research, 4Life
clinical findings now indicate that molecules in a
weight range between 250 — 3,000 daltons play important
regulatory roles in the immune system.
4Life
extracted and concentrated these nanofraction molecules
from cow colostrum for their proprietary NanoFactor™
extract, combining NanoFactor with their exclusive
Transfer Factor E-XF™ extract of transfer factors from
cow colostrum and chicken egg yolks to produce
4Life
Transfer Factor® Tri-Factor™ Formula, the most
comprehensive approach to immune system support
available today.
"I don't
know of another company in our category," said 4Life
Chief Scientific Officer Calvin McCausland, Ph.D. "In
2004, we were the first company to combine transfer
factors from cow colostrum and chicken egg yolks. In
2005, we introduced RioVida®, the world's only transfer
factor beverage. Now, the discovery of new immune
activity in nanofractions. When it comes to scientific
innovation, there's simply no comparison to 4Life."
4Life
Transfer Factor, Transfer Factor Plus®, and RioVida are
now fortified with the new Tri-Factor Formula. "We're
taking Tri-Factor Formula to the world because no other
product represents such a unique and indispensable
opportunity for a quality life," remarked 4Life
President Steve Tew.
David
Lisonbee: "At the end of the day, our distributors can
rest assured that 4Life will stay a good pace ahead of
the curve in the areas of science, service, and
success."
4Life,
global leader in the development, production, and
distribution of Transfer Factor immune support products,
continues to post growth in more than 40 countries
around the world.
View 4Life Transfer Factor History & The Extraction of
NanoFactor & The Making of Tri-Factor

4Life Transfer Factor® Products
Included in 2008 Physicians’ Desk Reference

Salt Lake
City, Utah (October 29, 2007) 4Life Research™ announced
today that 4Life Transfer Factor Products will be listed
in the 2008 Physicians’ Desk Reference: For
Nonprescription Drugs, Dietary Supplements, and Herbs(PDR).
“We are
thrilled once again to be part of this prestigious and
popular publication,” stated Director of Product
Development Chad Renshaw. “The PDR is yet another step
in educating the world about 4Life Transfer Factor and
its far-reaching health benefits.”
The 2008
edition of the PDR provides an explanation of the
recently announced 4Life Transfer Factor® and 4Life
Transfer Factor Plus® Tri-Factor™ Formulas, and includes
a listing of the 4Life Transfer Factor family products.
This professional listing gives 4Life Transfer Factor an
additional boost in the scientific community, and helps
strengthen every distributor’s position as an exclusive
leader in the distribution of 4Life Transfer Factor
products.
Director
of Health Information Services Brent Vaughan commented,
“Our 2008 listing provides 4Life Distributors with an
excellent resource when presenting our products to
potential prospects. It is also a great reference to
have in terms of added credibility, as the PDR is a
well-respected publication in the medical community.”
4Life,
the leader in the development, production, and
distribution of Transfer Factor support products,
continues to post growth in more than 40 countries
around the world.

4Life Transfer Factor®
Products Approved for Use by Olympic Athletes

|
Salt Lake City, Utah (December 4, 2007)
As first reported by 4Life Chief Scientific
Officer Calvin McCausland, Ph.D., in Direct
Selling News, 4Life received documentation
from the Federal Anti-Doping Center in
Moscow, Russia, that admits 4Life Transfer
Factor for use by Olympians in practice,
training, and competition. Approval was
obtained after volunteers consumed 4Life
Transfer Factor products and their bodily
fluids were analyzed in accordance with
doping control procedures that employ modern
methods of gas chromatography and
mass-spectrometry in compliance with the
World Anti-Doping Agency in Montreal,
Canada.
“We are very pleased by this approval,”
commented President of Eurasia Emma Oganova,
M.D., Ph.D. “4Life Transfer Factor continues
to define the cutting-edge of immune system
science.”
4Life Founder and Chief Executive Officer
David Lisonbee launched 4Life Research in
1998 with a commitment to the highest
scientific standards. Ongoing research and
development of Transfer Factor technology
has fueled 4Life’s constant growth and
maximized every distributor’s ability to
grow a successful independent business.
“Arguably, this kind of marketplace
positioning and high level product messaging
simply isn’t possible without the
involvement of a professional research and
development team,” added McCausland.
“I am pleased with our continued evolution
in the supplement industry,” stated
Executive Vice President Bruce Redd. “The
quality work of our Research and Development
department is certain to keep 4Life on the
leading edge of science and success for
years to come.”
4Life, the leader in the development,
production, and distribution of Transfer
Factor support products, continues to post
growth in more than 40 countries around the
world. |

Home
|
Company
|
Research
|
Products |
Purchase
|
TF &
Pets
|
ShapeRite |
FAQ |
News
|
Links
|
Opportunity
|
Contact Us |